Clinically validated shockwave therapy for insertional and mid-portion Achilles tendinopathy. Non-invasive, no surgery.
Effective for chronic cases that have not responded to rest, physiotherapy, or eccentric loading alone.
Understanding Achilles Tendinopathy
Achilles tendinopathy is one of the most common overuse injuries in both recreational and competitive athletes — but it is by no means restricted to people who run or play sport. Degenerative changes in the Achilles tendon can develop in anyone, and the resulting pain, stiffness, and reduced function can significantly limit daily activities for months or years.
There are two primary presentations. Mid-portion Achilles tendinopathy affects the tendon itself, typically 2–7cm above the heel bone, presenting as a fusiform swelling with localised tenderness. Insertional Achilles tendinopathy affects the point where the tendon meets the calcaneus (heel bone), often with associated calcification or bony prominence, and responds differently to rehabilitation protocols.
The challenge with both presentations is that tendon tissue has a relatively poor blood supply, making self-repair slow and unreliable. Eccentric loading exercises — the standard first-line treatment — help a significant proportion of mid-portion cases but have a much more limited evidence base for insertional tendinopathy. Cortisone injections provide temporary relief at the cost of weakening tendon tissue, increasing re-injury risk. Surgery carries meaningful downtime and is not without complication.
Shockwave therapy addresses this limitation directly. By delivering acoustic energy to the tendon, it stimulates the biological repair mechanisms that the tendon's limited vascularity otherwise restricts.
The Treatment
Extracorporeal shockwave therapy (ESWT) delivers focused acoustic pulses through the skin to the affected region of the Achilles tendon. At the cellular level, these pulses:
The combination of structural improvement and pain modulation makes ESWT effective not just as a pain suppressant but as a genuine treatment that promotes tendon healing. This is why clinical improvements are sustained at 12-month follow-up in published trials.
For insertional Achilles tendinopathy, shockwave therapy has a stronger evidence base than eccentric loading exercises — which can actually aggravate insertional presentations. This is a clinically important distinction that is often missed when patients receive generic Achilles rehabilitation advice.
Non-invasive
Preserves tendon strength
Per session
Continue light activity
You will be positioned comfortably with the affected leg accessible. Ultrasound gel is applied to the tendon area and the shockwave applicator is placed on the skin. You will feel rapid pulses — most patients describe a tapping or vibration sensation. Sessions last 15–20 minutes.
No anaesthetic is required. Mild local soreness for 24–48 hours following each session is normal. We advise avoiding high-impact Achilles loading (running, jumping) for 48 hours after each treatment. Low-impact activity — cycling, swimming, walking — is generally fine throughout the course.
Clinical Evidence
Multiple randomised controlled trials and systematic reviews support the use of ESWT for Achilles tendinopathy. A Cochrane-level systematic review comparing ESWT with other interventions found it significantly superior to eccentric loading for insertional Achilles tendinopathy, and comparable or superior for mid-portion cases when combined with a loading programme.
Insertional & mid-portion cases treated effectively
Typical recovery timeline post-treatment
Sustained improvement in published follow-up
For insertional Achilles tendinopathy, evidence from a 2012 RCT in the Journal of Orthopaedic & Sports Physical Therapy showed ESWT achieved significantly greater pain reduction and return-to-sport rates than eccentric loading alone at 4-month follow-up. The advantage was particularly pronounced in patients with radiological evidence of calcification at the tendon insertion.
For mid-portion Achilles tendinopathy, ESWT combined with a heavy slow resistance programme has been shown to be the most effective non-surgical intervention available, with outcomes comparable to surgical debridement in some trials — without the associated risks and recovery time.
Dr Bahl assesses each patient individually to determine the appropriate protocol for their specific presentation. Treatment approach differs between insertional and mid-portion cases.
Suitability
If you are unsure about your diagnosis, we can advise at your free consultation. Existing scans are helpful but not required.
What to Expect
Dr Bahl reviews your symptoms, duration, activity level, and any previous imaging. He distinguishes between insertional and mid-portion presentations to plan the correct protocol.
A course of 3–6 weekly sessions is designed for your specific presentation. Insertional and mid-portion cases use different treatment parameters. Costs are agreed before starting.
15–20 minutes per session. Continue light activity throughout. Avoid high-impact Achilles loading for 48 hours after each session. Mild soreness is normal.
We provide guidance on graduated loading and return-to-running timelines. Most runners can resume training within 6–12 weeks of completing treatment.
Why Choose Us
Insertional and mid-portion Achilles tendinopathy require different treatment parameters. We distinguish between them — and adjust accordingly, rather than applying a generic protocol.
All treatment by Dr Kishore Bahl, GMC-registered Medical Doctor (GMC No. 6070860) with 30 years' clinical experience. Doctor-led, not technician-led.
CE-marked shockwave devices used throughout — the same category of equipment as NHS and hospital-based centres. Evidence-based energy settings for tendinopathy treatment.
22 Notting Hill Gate, London W11 3JE — directly accessible from Notting Hill Gate tube station (Central and Circle lines). Easy access from Kensington, Chelsea, Bayswater, and beyond.
If shockwave therapy is not the most appropriate intervention for your Achilles problem, we will tell you — and recommend a better option. We don't recommend treatment that won't benefit you.
Pricing confirmed at your free consultation, before any commitment. No hidden costs. No pressure to book additional sessions beyond what is clinically appropriate.
Common Questions
Your Clinician
All treatment at Shockwave ReVibe is provided by Dr Kishore Bahl, a GMC-registered Medical Doctor with over 30 years of clinical experience in NHS and private practice. Dr Bahl holds BSc and MBBS degrees and is registered with the General Medical Council (GMC Registration No. 6070860).
Dr Bahl applies evidence-based shockwave protocols for musculoskeletal conditions, working exclusively with clinical-grade CE-marked equipment. He assesses every patient personally, distinguishes between insertional and mid-portion presentations, and designs the treatment approach accordingly.
Share your experience — your review helps others discover our clinic.